## **Core Concept**
Nocturnal enuresis, commonly known as nighttime bedwetting, is a condition where individuals involuntarily urinate during sleep. The management of nocturnal enuresis involves behavioral therapy, lifestyle modifications, and pharmacological interventions. The goal is to reduce the frequency of episodes and eventually achieve continence.

## **Why the Correct Answer is Right**
Desmopressin, a synthetic analogue of antidiuretic hormone (ADH), is widely used in the treatment of nocturnal enuresis. It works by increasing water reabsorption in the kidneys, thereby reducing urine production at night. Studies have shown that desmopressin has a significant efficacy in reducing the frequency of nocturnal enuresis episodes, with a lower recurrence rate compared to other treatments once therapy is stopped.

## **Why Each Wrong Option is Incorrect**
- **Option A:** Imipramine is a tricyclic antidepressant that has been used off-label for treating nocturnal enuresis. While it does have some effect, its mechanism is not fully understood, and it is not as effective as desmopressin in reducing recurrence.
- **Option B:** Oxybutynin is an anticholinergic medication used to treat overactive bladder and can be used for nocturnal enuresis. However, it has a higher recurrence rate compared to desmopressin once treatment is stopped.
- **Option C:** This option is not provided, but based on the correct answer being D, we can infer that the other options have higher recurrence rates.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that desmopressin has a high efficacy rate for reducing nocturnal enuresis episodes and is often recommended for short-term use to achieve continence, with a lower recurrence rate compared to other pharmacological treatments. It's essential to monitor patients for potential side effects and to taper off the medication to assess the need for continued therapy.

## **Correct Answer:** D. Desmopressin